Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Bassanelli M, Borro M, Roberto M, Giannarelli D, Giacinti S, Di Martino S, Ceribelli A, Russo A, Aschelter A, Scarpino S, Montori A, Pescarmona E, Tomao S, Simmaco M, Cognetti F, Milella M, Marchetti P. Bassanelli M, et al. Among authors: scarpino s. Cancers (Basel). 2021 Dec 30;14(1):178. doi: 10.3390/cancers14010178. Cancers (Basel). 2021. PMID: 35008342 Free PMC article.
Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC.
Melchior L, Hirschmann A, Hofman P, Bontoux C, Concha A, Mrabet-Dahbi S, Vannuffel P, Watkin E, Putzová M, Scarpino S, Cayre A, Martin P, Stoehr R, Hartmann A. Melchior L, et al. Among authors: scarpino s. Virchows Arch. 2024 Apr;484(4):677-686. doi: 10.1007/s00428-024-03778-9. Epub 2024 Mar 16. Virchows Arch. 2024. PMID: 38492039 Free PMC article.
Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification.
Mazzotta M, Filetti M, Rossi A, Roberto M, Occhipinti M, Pernazza A, Di Napoli A, Scarpino S, Vecchione A, Giusti R, Marchetti P. Mazzotta M, et al. Among authors: scarpino s. Ann Oncol. 2020 Mar;31(3):440-441. doi: 10.1016/j.annonc.2019.11.016. Epub 2019 Dec 9. Ann Oncol. 2020. PMID: 32067689 Free article. No abstract available.
Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation.
Leone A, Muscarella LA, Graziano P, Tornese A, Grillo LR, Di Lorenzo A, Bronzini M, Scarpino S, Sparaneo A, Rossi G. Leone A, et al. Among authors: scarpino s. Cancers (Basel). 2022 Dec 31;15(1):292. doi: 10.3390/cancers15010292. Cancers (Basel). 2022. PMID: 36612287 Free PMC article.
IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy.
Minniti G, Scaringi C, Arcella A, Lanzetta G, Di Stefano D, Scarpino S, Bozzao A, Pace A, Villani V, Salvati M, Esposito V, Giangaspero F, Enrici RM. Minniti G, et al. Among authors: scarpino s. J Neurooncol. 2014 Jun;118(2):377-383. doi: 10.1007/s11060-014-1443-0. Epub 2014 Apr 20. J Neurooncol. 2014. PMID: 24748470
Integrating the Idylla™ System Alongside a Real-Time Polymerase Chain Reaction and Next-Generation Sequencing for Investigating Gene Fusions in Pleural Effusions from Non-Small-Cell Lung Cancer Patients: A Pilot Study.
Scarpino S, Leone A, Galafate D, Pepe F, Malapelle U, Villani S, Giarnieri E, Maurizi G, De Vitis C, Mancini R, Mancini M, Di Napoli A, Vecchione A, Pilozzi E. Scarpino S, et al. Int J Mol Sci. 2024 Jul 11;25(14):7594. doi: 10.3390/ijms25147594. Int J Mol Sci. 2024. PMID: 39062837 Free PMC article.
141 results